Adaptive Biotechnologies
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell ADPT and other ETFs, options, and stocks.About ADPT
Adaptive Biotechnologies Corp. engages in the development of an immune medicine platform. Its products and services include immunoSEQ, clonoSEQ, cellular therapy, and vaccines.
ADPT Key Statistics
Stock Snapshot
As of today, Adaptive Biotechnologies(ADPT) shares are valued at $17.80. The company's market cap stands at 2.75B, with a P/E ratio of -33.53.
During the trading session on 2026-01-15, Adaptive Biotechnologies(ADPT) shares reached a daily high of $18.18 and a low of $17.56. At a current price of $17.80, the stock is +1.4% higher than the low and still -2.1% under the high.
Trading activity shows a volume of 1.87M, compared to an average daily volume of 2.37M.
Over the past 52 weeks, Adaptive Biotechnologies(ADPT) stock has traded between a high of $20.76 and a low of $6.26.
Over the past 52 weeks, Adaptive Biotechnologies(ADPT) stock has traded between a high of $20.76 and a low of $6.26.
ADPT News
Total revenue for the fourth quarter and full year 2025 was approximately $72M and $277M, representing an increase of 51% and 55%, respectively, over the corres...
Adaptive Biotechnologies recently announced that its subsidiary Digital Biotechnologies, Inc. began a Series A Preferred Stock round targeting up to US$15,000,0...
